Crystallization. Crystals of the DhaK–DhaL complex were obtained using the
Anion Suite screen (Qiagen). Optimization of conditions led to the best crystals
from hanging drop vapor diffusion at 19 °C by equilibrating 2 μL of protein
(10 mg∕ml) with 1 μL reservoir solution (0.1 M HEPES pH 7.5, 3.5 M sodium
formate) over 1 mL of reservoir solution. Crystals belong to space group
P41212 with unit cell dimensions a ¼ b ¼ 74.6, c ¼ 268.8 Å. Crystals of wild-
type DhaK and mutant enzymes were also obtained by hanging drop vapor
diffusion by equilibrating 1 μL of protein (2.5 mg∕ml of DhaK and 1.7 mg∕ml
of DhaL-his) with 1 μL reservoir solution (0.1 M sodium citrate pH 5.6, 20%
[w∕v] PEG 8000) over 1 mL of reservoir solution. Crystals of the wild-type DhaK
belong to space group P21 with a ¼ 49.8, b ¼ 91.5, c ¼ 73.2 Å, β ¼ 89.9°.
Crystals of H56AK and H56NK belong to space group P1 with unit cell dimen-
sions a ¼ 59.7, b ¼ 82.6, c ¼ 92.9 Å, α ¼ 77.9, β ¼ 78.1, γ ¼ 71.1°, whereas that
of the DhaK-H56NK-Dha complex form in space group P21 with a ¼ 82.2,
b ¼ 101.1, c ¼ 99.3 Å, β ¼ 89.95°. For data collection, crystals were transferred
to reservoir solution supplemented with 12% (v∕v) ethylene glycol and flash
cooled in a nitrogen stream at 100 K (Oxford Cryosystems).
was further purified by size exclusion (Superdex 200) in buffer containing
20 mM Tris pH 8, 300 mM NaCl, 1 mM DTT, 1 mM MgCl2, and 0.01 mM
ADP. Phosphotransferase reactions for specific activity measurements con-
tained 1 μM Enzyme I, 1 μM HPr, 0.5 μM DhaM, 0.5 μM DhaL, 0.5 μM DhaK,
50 mM potassium phosphate pH 7.5, 16 mM Dha, 2.5 mM DTT, 2.5 mM MgCl2,
2 units glycerol-3-phosphate dehydrogenase (Sigma Chemical Co.), and 1 mM
NADH and were initiated by the addition of 2 mM PEP. The glycerol-3-phos-
phate dehydrogenase coupling enzyme uses NADH to convert Dha-P to gly-
cerol-3-phosphate. The production of Dha-P in the reaction was followed by
monitoring oxidation of NADH at 340 nm in a Spectramax 250 plate reader at
room temperature. The effect of glycerol on phosphotransferase activity for
wild-type, H56AK and H56NK was examined for reactions in the presence of
10 mM, 100 mM and 1 M glycerol. kcatapp was measured for wild-type enzyme
from coupled phosphotransferase reactions (0–1.6 mM Dha) containing
0.5 μM Enzyme I, 0.5 μM HPr, 0.25 μM DhaM, 0.25 μM DhaL, 0.25 μM DhaK,
50 mM potassium phosphate pH 7.5, 2.5 mM DTT, 2.5 mM MgCl2, 2 units
glycerol-3-phosphate dehydrogenase (Sigma Chemical Co.), and
1 mM
NADH, initiated by addition of 2 mM PEP. These conditions are similar to
those reported previously (8), and kinetic constants were derived by varying
concentration of Dha only, leading to apparent values of kinetic parameters.
X-ray Data Collection, Structure Solution, and Refinement. Diffraction data for
free DhaK and the DhaK–DhaL complex were collected to 2.2 Å at the 31-ID
beamline (LRL-CAT), Advanced Photon Source, Argonne National Laboratory.
Data integration and scaling were performed with the program HKL2000
(15). Structure determination was performed by molecular replacement
using the program Phaser (16) from the CCP4 suite with the previously
reported E. coli DhaK (PDB 1OI2) (2) and DhaL (PDB ID code 2BTD) (4) struc-
tures as the search models. Refinement was carried out with the program
Refmac5 (17) with final Rwork∕Rfree of 0.172∕0.210 and 0.189∕0.225 for
DhaK and DhaK–DhaL, respectively. Diffraction data for crystals of DhaK
mutant enzymes were collected to 2.55 Å (H56AK), 1.97 Å (H56NK) and
2.2 Å (H56NK-Dha) at the CMCF1 beamline at the Canadian Light Source.
Data processing and structure determination was done similarly as described
above. All models have good geometry as analyzed with PROCHECK (18).
Final data collection and refinement statistics are shown in Table S1.
Due to the limited sensitivity of the assay for wild-type enzyme seen at
app
low substrate concentrations an accurate value for Km
could not be deter-
mined. For H56AK and H56NK, kcat
and Km
were determined from
app
app
reactions containing 1 μM Enzyme I, 1 μM HPr, 0.5 μM DhaM, 0.5 μM DhaL,
and 0.5 μM DhaK at a range from 0–16 mM and 0–64 mM Dha, respectively.
Values were calculated by nonlinear regression fit to a hyperbola.
ACKNOWLEDGMENTS. We thank Dr. Shaunivan Labiuk (Canadian Light Source;
CLS) for collecting several datasets; John Wagner, Ming-Ni Hung, and Linhua
Zhang for cloning; and Drs. Traian Sulea, Enrico O. Purisima, and Stephan
Grosse for helpful discussions. This research was supported by Canadian
Institutes of Health Research (CIHR) Grant MOP-48370 (I.E., A.M., and M.C.).
X-ray diffraction data for this study were measured at Lilly Research Labora-
tory Collaborative Access Team (LRL-CAT) at the Advanced Photon Source,
Argonne National Laboratory and at CMCF1 at CLS. Use of the Advanced
Photon Source at Argonne National Laboratory was supported by the US
Department of Energy, Office of Science, Office of Basic Energy Sciences,
under Contract DE-AC02-06CH11357. Use of the LRL-CAT beamline at Sector
31 of the Advanced Photon Source was provided by Eli Lilly & Company,
which operates the facility. The Canadian Macromolecular Crystallography
Facility is supported by the Canadian Foundation for Innovation, the Natural
Sciences and Engineering Research Council of Canada, and CIHR. This is NRCC
publication 50686.
Molecular Dynamics Simulations. The DhaK–DhaL–ATP, DhaK–DhaL–syn–ADP,
and DhaK–DhaL–anti–ADP complexes were sampled by 5-ns MD simulations
using the AMBER10 suite of programs (19) together with the AMBER ff03
force field for the proteins and a modified force field for ATP and ADP
(20). Details of the calculations are available in SI Text.
Phosphotransferase Assay. Phosphorylation of Dha was measured in
a
coupled assay similar to that described previously (1). To remove residual
endogenous DhaK that could copurify with recombinant DhaL, the latter
1. Gutknecht R, Beutler R, Garcia-Alles LF, Baumann U, Erni B (2001) The dihydroxyace-
tone kinase of Escherichia coli utilizes a phosphoprotein instead of ATP as phosphoryl
donor. EMBO J 20:2480–2486.
2. Siebold C, Garcia-Alles LF, Erni B, Baumann U (2003) A mechanism of covalent substrate
binding in the x-ray structure of subunit K of the Escherichia coli dihydroxyacetone
kinase. Proc Natl Acad Sci USA 100:8188–8192.
3. Bächler C, Flükiger-Brühwiler K, Schneider P, Bähler P, Erni B (2005) From ATP as
substrate to ADP as coenzyme: Functional evolution of the nucleotide binding subunit
of dihydroxyacetone kinases. J Biol Chem 280:18321–18325.
4. Oberholzer AE, Schneider P, Baumann U, Erni B (2006) Crystal structure of the nucleo-
tide-binding subunit DhaL of the Escherichia coli dihydroxyacetone kinase. J Mol Biol
359:539–545.
10. Verschueren KH, Seljée F, Rozeboom HJ, Kalk KH, Dijkstra BW (1993) Crystallographic
analysis of the catalytic mechanism of haloalkane dehalogenase. Nature 363:693–698.
11. Heine A, et al. (2001) Observation of covalent intermediates in an enzyme mechanism
at atomic resolution. Science 294:369–374.
12. Jin RZ (1982) Glycerol kinase as a substitute for dihydroxyacetone kinase in a mutant of
Klebsiella pneumoniae. J Bacteriol 152:1303–1307.
13. Johnson EA, Burke SK, Forage RG, Lin EC (1984) Purification and properties of
dihydroxyacetone kinase from Klebsiella pneumoniae. J Bacteriol 160:55–60.
14. Bächler C, Schneider P, Bähler P, Lustig A, Erni B (2005) Escherichia coli dihydroxyace-
tone kinase controls gene expression by binding to transcription factor DhaR. EMBO J
24:283–293.
5. Siebold C, Arnold I, Garcia-Alles LF, Baumann U, Erni B (2003) Crystal structure of the
Citrobacter freundii dihydroxyacetone kinase reveals an eight-stranded alpha-helical
barrel ATP-binding domain. J Biol Chem 278:48236–48244.
15. Otwinowski Z, Minor W (1997) Processing of X-ray diffraction data collected in
oscillation mode. Methods Enzymol 276:307–326.
16. McCoy AJ (2007) Solving structures of protein complexes by molecular replacement
with Phaser. Acta Crystallogr D 63:32–41.
6. Zurbriggen A, et al. (2008) X-ray structures of the three Lactococcus lactis dihydrox-
yacetone kinase subunits and of
a transient intersubunit complex. J Biol Chem
17. Murshudov GN, Vagin AA, Lebedev A, Wilson KS, Dodson EJ (1999) Efficient anisotro-
pic refinement of macromolecular structures using FFT. Acta Crystallogr D 55:247–255.
18. Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: A program to
check the stereochemical quality of protein structures. J Appl Crystallogr 26:283–291.
19. Case DA, et al. (2005) The Amber biomolecular simulation programs. J Comput Chem
26:1668–1688.
283:35789–35796.
7. Allen KN, Dunaway-Mariano D (2004) Phosphoryl group transfer: Evolution of a
catalytic scaffold. Trends Biochem Sci 29:495–503.
8. Garcia-Alles LF, et al. (2004) Phosphoenolpyruvate- and ATP-dependent dihydroxyace-
tone kinases: Covalent substrate-binding and kinetic mechanism. Biochemistry
43:13037–13045.
20. Meagher KL, Redman LT, Carlson HA (2003) Development of polyphosphate
parameters for use with the AMBER force field. J Comput Chem 24:1016–1025.
9. Lahiri SD, Zhang G, Dunaway-Mariano D, Allen KN (2003) The pentacovalent
phosphoryl transfer reaction. Science 299:2067–2071.
Shi et al.
PNAS
∣
January 25, 2011
∣
vol. 108
∣
no. 4
∣
1307